Faculty and trainees in the laboratory of Chiara Giannarelli, MD, PhD, are recognized for their innovative research. Read more about our accomplishments.

Awards

2023

Natalia Eberhardt received the Outstanding Presentation Award for her talk “SARS-CoV-2 infection of human vessels triggers pro-atherogenic inflammatory responses” at the Cardiovascular Research Center Annual Symposium, NYU Grossman School of Medicine, New York, NY

2022

Letizia Amadori received the Best Oral Presentation Award - NYU Langone Cardiovascular Research Center Retreat, New York, NY

Letizia Amadori recognized with Best Poster Award - NYU Langone Immunology Retreat, New York, NY

Natalia Eberhardt was awarded the Atherosclerosis, Thrombosis and Vascular Biology Council Scientific Sessions Travel Grant for Early Career Investigators, Chicago, IL

Natalia Eberhardt was awarded AHA Research Supplement to Promote Diversity in Science to study the role of T cell senescence in pathological effects of type 2 diabetes on atherosclerosis.

2019

The Paul Dudley White International Scholar Award recognizes the highest-ranked abstract from the United States, and is presented at the Annual Meeting of the American Heart Association. In the 2019 Vascular Discovery: from Genes to Medicine Scientific Session, the winning abstract was authored by Dawn M. Fernandez, PhD, titled “Single-Cell Profiling of Atherosclerotic Tissue Identifies T Cell Subsets Associated with Cerebrovascular Events.” In the paper, Dr. Fernandez explains that plaque in arteries may not all be the same, and targeting specific immune cells in plaque may reduce heart attack and stroke risk. These findings also show that T-cells in arterial plaque could signal stroke risk.

Dr. Fernandez’ work was also recognized by the Society for Vascular Surgery who named “Single-Cell Profiling of Atherosclerotic Tissue Identifies T Cell Subsets Associated with Cerebrovascular Events” the best abstract poster presentation in the category of Atherobiology/Novel Models in 2019.

In the News

July 21, 2022. Chiara Giannarelli Featured EAS 2022 Plenary Session Speaker “Deep Phenotyping of Atherosclerotic Disease” Symposium Review on Plenary Session 90th European Atherosclerosis Society (EAS) Congress in Milan” EMJ Cardioogyl. 2022; 10[Suppl 3]:02-10.

June 8, 2023. The Giannarelli Laboratory Identified a New Use for Experimental Cancer Drug That May Slow Inflammation in Atherosclerosis.

September 11, 2020. Dr. Giannarelli was the keynote speaker at the 2020 Research Retreat hosted by the Department of Pharmacological Sciences at Icahn School of Medicine at Mount Sinai.

October 7, 2019. A team of Mount Sinai researchers that included Dr. Giannarelli was the first to discover single cell immune composition of plaques from stroke patients.